Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 25;58(4):e01345-19.
doi: 10.1128/JCM.01345-19. Print 2020 Mar 25.

Diagnostic Mycology: Xtreme Challenges

Affiliations
Review

Diagnostic Mycology: Xtreme Challenges

Brian L Wickes et al. J Clin Microbiol. .

Abstract

Developing any diagnostic assay that receives United States Food and Drug Administration (FDA) approval can be a slow and difficult process. FDA-approved assays for fungal diagnosis are generally few in number and are focused mainly on diagnosing candidiasis, which is caused by several species of Candida, in addition to a limited number of systemic mycotic agents. While all microbial diagnostic assays face challenges before they are FDA approved and reach the market, there are a number of challenges to fungal diagnostic assay development that have been difficult hurdles to overcome. These hurdles include template preparation, fungal morphology, how many fungi should be identified in a single assay (scope), taxonomy and nomenclature, discriminating colonizers from invasive infection, combining identification with antifungal susceptibility, and navigating the administrative hurdles required to integrate an assay into a clinical laboratory. Some of these challenges are easier to overcome than others, but all seem to be particularly difficult for fungal diagnostic assays.

Keywords: antifungal; molds; mycoses; nomenclature; susceptibility testing; yeast.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Dimorphism in Candida albicans. C. albicans is an example of a dimorphic fungus. These fungi can grow as budding yeast or true septate hyphae. C. albicans also can produce pseudohyphae and, depending on culture conditions and duration, chlamydospores. Depending on the type of assay, morphology can affect the outcome or it can determine whether the culture can even be run on a specific assay or instrument. (A) C. albicans yeast cells grown in broth culture for 20 h. Bar = 10 μm. (B) C. albicans grown in broth culture showing predominantly hyphal growth. Bar = 10 μm. (C) C. albicans growing on agar medium as a typical yeast colony with a creamy texture and smooth surface. Bar = 1.0 cm. (D) C. albicans growing on agar medium showing a rough colony morphology that has hyphae growing under the colony. Bar = 1.0 cm. (Images courtesy of David Kadosh, reproduced with permission.)

References

    1. Kozel TR, Wickes B. 2014. Fungal diagnostics. Cold Spring Harb Perspect Med 4:a019299. doi:10.1101/cshperspect.a019299. - DOI - PMC - PubMed
    1. Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O'Connell H, Noble-Wang J, Rao C, Balajee SA, Chiller T. 2014. Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J 33:472–476. doi:10.1097/INF.0000000000000261. - DOI - PubMed
    1. Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, Etienne K, Deak E, Derado G, Shieh WJ, Drew C, Zaki S, Sugerman D, Gade L, Thompson EH, Sutton DA, Engelthaler DM, Schupp JM, Brandt ME, Harris JR, Lockhart SR, Turabelidze G, Park BJ. 2012. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med 367:2214–2225. doi:10.1056/NEJMoa1204781. - DOI - PubMed
    1. Larone DH, Walsh TJ. 2013. Exserohilum rostratum: anatomy of a national outbreak of fungal meningitis. Clin Microbiol News 35:185–193. doi:10.1016/j.clinmicnews.2013.11.001. - DOI
    1. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, Candida auris Incident Management Team, Manuel R, Brown CS. 2018. Candida auris: a review of the literature. Clin Microbiol Rev 31:e00029-17. doi:10.1128/CMR.00029-17. - DOI - PMC - PubMed

Publication types

Substances